Sanofi US

Registered Principal Details

Business Or Interest:
Pharmaceutical Manufacturing

Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.

CEO Name:
Paul Hudson

Contact
DC
Deanne Calvert
1122 E. Pike Street, #1002
Seattle, WA 98122
(206) 320-0536
compliance_wa_sanofi@multistate.us
http://www.sanofi.us

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 103
Assembly Bill 103
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.

Bill Text and History

For
Notification Date
3/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 773
Assembly Bill 773
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
12/11/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 100
Senate Bill 100
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.

Bill Text and History

For
Notification Date
3/2/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 737
Senate Bill 737
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
12/4/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
2/23/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Insurance: Departmentwide
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide

Notification Date
2/23/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Administrative Rulemaking Proceedings

Immunization of students
Agency Name
Department of Health Services (DHS)
Subject
Immunization of students
Scope Statement
SS 067_17
For
Notification Date
2/24/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

2025-27 Biennial Budget Bill
Development, drafting or introduction of a proposal relating to
2025-27 Biennial Budget Bill

Action Intended To Affect
Legislative matter

Notification Date
9/18/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Rare Diseases
Development, drafting or introduction of a proposal relating to
Rare Diseases

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/18/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Newborn Screening
Development, drafting or introduction of a proposal relating to
Newborn Screening

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/18/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Immunization Regulations
Development, drafting or introduction of a proposal relating to
Immunization Regulations

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/8/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Diabetes Education
Development, drafting or introduction of a proposal relating to
Diabetes Education

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/8/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Application of prescription drug payments for health coverage
Development, drafting or introduction of a proposal relating to
Application of prescription drug payments for health coverage

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/19/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

2023-25 Biennial Budget Bill
Development, drafting or introduction of a proposal relating to
2023-25 Biennial Budget Bill

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/19/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2023
January - June
2023
July - December
2024
January - June
Total
Total Lobbying Expenditures 2023
January - June
$16,530.00
2023
July - December
$17,100.00
2024
January - June
$17,000.00
Total $50,630.00
Total Hours Communicating 2023
January - June
9.10
2023
July - December
11.60
2024
January - June
1.30
Total 22.00
Total Hours Other 2023
January - June
29.05
2023
July - December
33.15
2024
January - June
21.90
Total 84.10

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
30%
2023
July - December
10%
2024
January - June
2024
July - December
Total 14%
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
30%
2023
July - December
25%
2024
January - June
2024
July - December
Total 21%
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
10%
2024
January - June
2024
July - December
Total 4%
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
25%
2024
January - June
2024
July - December
Total 10%

Budget Bill Subjects

2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
10%
2023
July - December
2024
January - June
2024
July - December
Total 4%
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
10%
2023
July - December
2024
January - June
2024
July - December
Total 4%

Administrative Rulemaking Proceedings

2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
10%
2023
July - December
2024
January - June
2024
July - December
Total 4%

Topics Not Yet Assigned A Bill Or Rule Number

2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
10%
2023
July - December
2024
January - June
2024
July - December
Total 4%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
30%
2024
January - June
100%
2024
July - December
Total 35%

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures